Facebook Linkedin RSS Twitter Youtube
Home 2023

FDA review

Insilico Gains FDA’s First Orphan Drug Designation for AI Candidate
Artificial Intelligence

Insilico Gains FDA’s First Orphan Drug Designation for AI Candidate

Alex Philippidis -
0
Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing
Drug Discovery

Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing

Sophia Ktori -
0
Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus
Drug Discovery

Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus

Alex Philippidis -
0
Mechanism Underpinning “Chemo-Brain” Identified, Points to Existing Drug as Potential Therapy
Cancer

Mechanism Underpinning “Chemo-Brain” Identified, Points to Existing Drug as Potential Therapy

Sophia Ktori -
0
Recombinant Proteins Benefit the Clinical Diagnostic Industry
Cancer

Recombinant Proteins Benefit the Clinical Diagnostic Industry

Kathy Vuksanaj -
0
Precision Medicine Marshals Its Resources
Drug Discovery

Precision Medicine Marshals Its Resources

Kathy Vuksanaj -
0
FDA Approves Bluebird Bio’s Lentiviral Gene Therapy to Treat Beta-Thalassemia
Genome Editing

FDA Approves Bluebird Bio’s Lentiviral Gene Therapy to Treat Beta-Thalassemia

Julianna LeMieux, PhD -
0
Mathematical Modeling in Biopharma: More than the Sum of Its Parts
Bioprocessing

Mathematical Modeling in Biopharma: More than the Sum of Its Parts

John Sterling -
0
Synthesis of Bacterium’s Anticancer Warhead Described
Cancer

Synthesis of Bacterium’s Anticancer Warhead Described

Sophia Ktori -
0
Busy Bees: Hexagon Bio Combs Nature’s DNA to Unlock Next-Gen Medicines
Cancer

Busy Bees: Hexagon Bio Combs Nature’s DNA to Unlock Next-Gen Medicines

Alex Philippidis -
0
123...10Page 1 of 10
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.